APA

Mezzanzanica D., Garrido M. A., Neblock D. S., Daddona P. E., Andrew S. M., Zurawski V. R., Segal D. M. & Wunderlich J. R. (19911113). Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab')2 antibody prolong host survival in a murine xenograft model. : Cancer research.

Chicago

Mezzanzanica D, Garrido M A, Neblock D S, Daddona P E, Andrew S M, Zurawski V R, Segal D M and Wunderlich J R. 19911113. Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab')2 antibody prolong host survival in a murine xenograft model. : Cancer research.

Harvard

Mezzanzanica D., Garrido M. A., Neblock D. S., Daddona P. E., Andrew S. M., Zurawski V. R., Segal D. M. and Wunderlich J. R. (19911113). Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab')2 antibody prolong host survival in a murine xenograft model. : Cancer research.

MLA

Mezzanzanica D, Garrido M A, Neblock D S, Daddona P E, Andrew S M, Zurawski V R, Segal D M and Wunderlich J R. Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab')2 antibody prolong host survival in a murine xenograft model. : Cancer research. 19911113.